Oppenheimer (OPY) Stock Forecast, Price & News

Oppenheimer's stock was trading at $42.33 at the beginning of the year. Since then, OPY stock has decreased by 10.7% and is now trading at $37.80.
View the best growth stocks for 2023 here.

Oppenheimer saw a decline in short interest in August. As of August 15th, there was short interest totaling 25,400 shares, a decline of 38.6% from the July 31st total of 41,400 shares. Based on an average daily volume of 67,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.4% of the shares of the company are sold short.
View Oppenheimer's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023.
View our OPY earnings forecast.

Oppenheimer Holdings Inc. (NYSE:OPY) released its earnings results on Friday, July, 28th. The financial services provider reported ($0.85) EPS for the quarter. The financial services provider earned $306.19 million during the quarter. Oppenheimer had a net margin of 2.60% and a trailing twelve-month return on equity of 4.07%.

Oppenheimer announced a quarterly dividend on Friday, July 28th. Stockholders of record on Friday, August 11th will be paid a dividend of $0.15 per share on Friday, August 25th. This represents a $0.60 annualized dividend and a yield of 1.59%. The ex-dividend date is Thursday, August 10th.
Read our dividend analysis for OPY.

Oppenheimer (NYSE:OPY) pays an annual dividend of $0.60 per share and currently has a dividend yield of 1.60%. The dividend payout ratio is 22.99%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for OPY.

113 employees have rated Oppenheimer Chief Executive Officer Albert G. Lowenthal on Glassdoor.com. Albert G. Lowenthal has an approval rating of 43% among the company's employees. This puts Albert G. Lowenthal in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oppenheimer investors own include AbbVie (ABBV), International Business Machines (IBM), Pfizer (PFE), Verizon Communications (VZ), Waddell & Reed Financial (WDR), Exxon Mobil (XOM), Boeing (BA), ChemoCentryx (CCXI), Salesforce (CRM) and Editas Medicine (EDIT).

Oppenheimer trades on the New York Stock Exchange (NYSE) under the ticker symbol "OPY."

Oppenheimer's stock is owned by a number of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (4.93%), BlackRock Inc. (1.88%), RBF Capital LLC (1.58%), Renaissance Technologies LLC (0.69%), Geode Capital Management LLC (0.69%) and Profit Investment Management LLC (0.63%). Insiders that own company stock include A Winn Oughtred, Dennis P Mcnamara, Evan Behrens and Jeffrey J Alfano.
View institutional ownership trends.

Shares of OPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OPY stock can currently be purchased for approximately $37.80.

Oppenheimer (NYSE:OPY) has a market capitalization of $398.79 million and generates $1.11 billion in revenue each year. The financial services provider earns $32.35 million in net income (profit) each year or $2.61 on an earnings per share basis.

The company employs 2,912 workers across the globe.

Oppenheimer's mailing address is 85 BROAD STREET, NEW YORK NY, 10004. The official website for the company is www.oppenheimer.com. The financial services provider can be reached via phone at (212) 668-8000, via email at info@opco.com, or via fax at 212-943-8728.